Determination and validation of a solid-phase extraction gas chromatography-mass spectrometry for the quantification of methadone and its principal metabolite in human plasma

8Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study aimed to develop a solid-phase extraction gas chromatography-selected ion monitoring-mass spectrometry method for the determination of methadone (MDN) and 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) in human plasma. The linear response was obtained over the concentration range from 10 to 2000 ng/mL for MDN and EDDP. The absolute recoveries of MDN and EDDP were 95.9%-98.9% and 94.8%-102.4%, with relative standard deviation (RSD) ranging from 1.8% to 2.7% and 1.8% to 3.9%, respectively. The intra- and interday precisions were found to be less than 5% for both analytes. The limits of detection of MDN and EDDP were 4 and 5 ng/mL, respectively. The presented method was convenient for therapeutic drug monitoring and pharmacokinetic studies in patients on heroin-assisted MDN therapy.

Author supplied keywords

Cite

CITATION STYLE

APA

Chiadmi, F., & Schlatter, J. (2015). Determination and validation of a solid-phase extraction gas chromatography-mass spectrometry for the quantification of methadone and its principal metabolite in human plasma. Analytical Chemistry Insights, 10(1), 17–22. https://doi.org/10.4137/Aci.s25554

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free